A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia

NCT00463385 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis With Myeloid Metaplasia
Myeloid Metaplasia
Myelofibrosis

Interventions

DRUG: Pomalidomide
DRUG: Prednisone
DRUG: Placebo to pomalidomide
DRUG: Placebo to prednisone

Sponsor

Celgene